Profiel
Gene Kim worked as an Executive Director-Financial Planning & Analysis at Versartis, Inc. from 2013 to 2018.
He then served as a Vice President-Finance at Kaleido Biosciences, Inc. from 2018 to 2020.
Currently, he holds the position of Vice President-Finance at Dyne Therapeutics, Inc. Mr. Kim completed his undergraduate degree at the University of California, Los Angeles.
Eerdere bekende functies van Gene Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01-01-2020 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01-05-2018 |
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | - |
Opleiding van Gene Kim
| University of California, Los Angeles | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
